Brief: Biogen To Buy Apellis For $5.6 Billion To Boost Kidney Franchise - Bloomberg News
31/03/2026 11:53
March 31 (Reuters) - BIOGEN TO BUY APELLIS FOR $5.6 BILLION TO BOOST KIDNEY FRANCHISE - BLOOMBERG NEWS BIOGEN WILL PAY $41 A SHARE FOR APELLIS- BLOOMBERG NEWS Source text: https://tinyurl.com/3yvcd6bn ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout